Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $1.79 billion. The enterprise value is $1.23 billion.
| Market Cap | 1.79B |
| Enterprise Value | 1.23B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 140.13 million shares outstanding. The number of shares has increased by 16.64% in one year.
| Current Share Class | 140.13M |
| Shares Outstanding | 140.13M |
| Shares Change (YoY) | +16.64% |
| Shares Change (QoQ) | +12.65% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 98.98% |
| Float | 134.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.00 |
| Forward PS | 30.34 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.65, with a Debt / Equity ratio of 0.10.
| Current Ratio | 6.65 |
| Quick Ratio | 5.61 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -55.44% and return on invested capital (ROIC) is -32.70%.
| Return on Equity (ROE) | -55.44% |
| Return on Assets (ROA) | -30.14% |
| Return on Invested Capital (ROIC) | -32.70% |
| Return on Capital Employed (ROCE) | -54.45% |
| Weighted Average Cost of Capital (WACC) | 13.69% |
| Revenue Per Employee | $157,841 |
| Profits Per Employee | -$1.06M |
| Employee Count | 377 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.64% in the last 52 weeks. The beta is 1.82, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 1.82 |
| 52-Week Price Change | +5.64% |
| 50-Day Moving Average | 12.84 |
| 200-Day Moving Average | 12.57 |
| Relative Strength Index (RSI) | 52.15 |
| Average Volume (20 Days) | 3,138,206 |
Short Selling Information
The latest short interest is 44.88 million, so 32.03% of the outstanding shares have been sold short.
| Short Interest | 44.88M |
| Short Previous Month | 44.01M |
| Short % of Shares Out | 32.03% |
| Short % of Float | 33.45% |
| Short Ratio (days to cover) | 12.31 |
Income Statement
In the last 12 months, NTLA had revenue of $59.51 million and -$399.98 million in losses. Loss per share was -$3.34.
| Revenue | 59.51M |
| Gross Profit | -222.82M |
| Operating Income | -423.48M |
| Pretax Income | -399.98M |
| Net Income | -399.98M |
| EBITDA | -414.40M |
| EBIT | -423.48M |
| Loss Per Share | -$3.34 |
Balance Sheet
The company has $437.76 million in cash and $73.41 million in debt, with a net cash position of $554.94 million or $3.96 per share.
| Cash & Cash Equivalents | 437.76M |
| Total Debt | 73.41M |
| Net Cash | 554.94M |
| Net Cash Per Share | $3.96 |
| Equity (Book Value) | 727.71M |
| Book Value Per Share | 5.20 |
| Working Capital | 448.44M |
Cash Flow
In the last 12 months, operating cash flow was -$346.64 million and capital expenditures -$2.04 million, giving a free cash flow of -$348.69 million.
| Operating Cash Flow | -346.64M |
| Capital Expenditures | -2.04M |
| Depreciation & Amortization | 9.08M |
| Net Borrowing | n/a |
| Free Cash Flow | -348.69M |
| FCF Per Share | -$2.49 |
Margins
| Gross Margin | n/a |
| Operating Margin | -711.66% |
| Pretax Margin | -672.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.64% |
| Shareholder Yield | -16.64% |
| Earnings Yield | -22.40% |
| FCF Yield | -19.53% |
Analyst Forecast
The average price target for NTLA is $23.94, which is 87.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.94 |
| Price Target Difference | 87.91% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 76.17% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of 1.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 4 |